A new mouse model may be critical for understanding the most aggressive types of pancreatic cancer and finding ways to prevent its growth and recurrence.
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
The symposium will feature keynotes by Margaret Foti, chief executive at AACR, and Ned Sharpless, former director of the NCI, along with talks from leading members of the cancer center.
Columbia researchers have found that a protein released by multiple myeloma cells prevents the immune system from attacking the cancer, a finding that could lead to better treatments.
Researchers have found why cancer cells in oxygen-depleted environments are forced to rely on fat imports, a finding that could lead to new ways to understand and slow down tumor growth.
The program brings together physicians and nurse practitioners from multiple disciplines to provide care for smokers and ex-smokers who are at high risk for lung cancer and other complications.
Columbia geneticist Wendy Chung reflects on the progress made in cancer genetics and discusses the next frontier of using genetic information to design personalized cancer prevention strategies.